Presidio Ventures logo

Presidio Ventures

Crunchbase
Pitchbook
Crunchbase

Deals on record

5

Common Fundraising Type

Equity

Outrider logo
Outrider

Autonomous

Koch Disruptive Technologies logo
Prologis Ventures logo
Presidio Ventures logo
NVentures logo
New Enterprise Associates logo
Lineage Ventures logo
Interwoven Ventures logo
Goose Capital logo

Outrider develops self-driving electric yard trucks to automate logistics operations in distribution centers, intermodal rail, and port terminals.

Series D
$62M
10/25/2024
Article
Fortera logo
Fortera

Low-carbon cement

Wollemi Capital logo
Temasek logo
Saint-Gobain logo
Presidio Ventures logo
Khosla Ventures logo
Alumni Ventures logo

Fortera is a materials technology company that has developed a process to produce low-carbon cement by capturing and converting CO2 emissions from existing cement production infrastructure.

Series C
$85M
08/20/2024
Article
Nu Quantum logo
Nu Quantum

Quantum Networking

University of Cambridge logo
Seraphim Capital logo
Presidio Ventures logo
National Security Strategic Investment Fund logo
Martlet logo
IQ Capital logo
Expeditions Fund logo
Deeptech Labs logo

Nu Quantum is a quantum networking company that provides a quantum networking infrastructure essential to scaling quantum computers.

Series A
$8.5M
11/02/2023
Article
Peregrine Hydrogen logo
Peregrine Hydrogen

Climate Technology

Schox logo
RiSC Capital logo
Presidio Ventures logo
Gates Frontier logo
Builders logo
Bidra logo

Peregrine Hydrogen is a climate technology company that offers proprietary technology to co-produce clean hydrogen and valuable commodity chemicals, with an initial focus on decarbonizing hydrogen for ammonia production in fertilizer applications.

Seed
$7.8M
09/25/2023
Article
Atropos Health logo
Atropos Health

Healthcare Technology

Presidio Ventures logo
Samsung Next logo
Gaingels logo
Audere Capital logo

Atropos Health provides a cloud-based platform for faster data evaluation, evidence generation, and Generative AI innovation in healthcare, aiming to revolutionize health decisions and improve patient outcomes globally.

Equity
Undisclosed
09/21/2023
Article